MENEST Drug Patent Profile
✉ Email this page to a colleague
When do Menest patents expire, and when can generic versions of Menest launch?
Menest is a drug marketed by Monarch Pharms and is included in four NDAs.
The generic ingredient in MENEST is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MENEST?
- What are the global sales for MENEST?
- What is Average Wholesale Price for MENEST?
Summary for MENEST
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 109 |
| Patent Applications: | 4,178 |
| Drug Prices: | Drug price information for MENEST |
| DailyMed Link: | MENEST at DailyMed |
US Patents and Regulatory Information for MENEST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monarch Pharms | MENEST | estrogens, esterified | TABLET;ORAL | 084951-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Monarch Pharms | MENEST | estrogens, esterified | TABLET;ORAL | 084949-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Monarch Pharms | MENEST | estrogens, esterified | TABLET;ORAL | 084948-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Monarch Pharms | MENEST | estrogens, esterified | TABLET;ORAL | 084950-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
